These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3569868)

  • 41. HLA and multiple sclerosis: population and families study.
    Govaerts A; Gony J; Martin-Mondiére C; Poirier JC; Schmid M; Schuller E; Degos JD; Dausset J
    Tissue Antigens; 1985 Apr; 25(4):187-99. PubMed ID: 3874450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strong linkage disequilibrium between HLA-Dw2 and and BfS in multiple sclerosis and in the normal population.
    Stewart GJ; Basten A; Kirk RL
    Tissue Antigens; 1979 Aug; 14(2):86-97. PubMed ID: 91230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenetic studies of multiple sclerosis patients in Caithness County, Scotland.
    Robertson P; Ward P; Brostoff J; Pack S; Festenstein H; Sacks J; Rosenberg RA; Peters E; Stenning P; Zabriskie JB
    Neuropathol Appl Neurobiol; 1980; 6(4):299-305. PubMed ID: 7413014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The genetics of susceptibility to multiple sclerosis.
    Spielman RS; Nathanson N
    Epidemiol Rev; 1982; 4():45-65. PubMed ID: 6754409
    [No Abstract]   [Full Text] [Related]  

  • 45. C4B3 allotype with a novel Ch phenotype.
    Skanes VM; Larsen B; Giles CM
    Immunogenetics; 1985; 22(6):609-16. PubMed ID: 3865894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A linkage analysis of the Gm locus and multiple sclerosis.
    Haile RW; Goldstein A; Field L; Marazita ML
    Genet Epidemiol; 1985; 2(1):29-34. PubMed ID: 3876966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-Dw1 and BfF as protective markers in multiple sclerosis.
    Ilonen J; Lagerstedt A; Koskimies S; Reunanen M
    J Neuroimmunol; 1983 Dec; 5(3):283-8. PubMed ID: 6558078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sporadic and familial-occurring multiple sclerosis. HLA typing and study of chromosomal sister chromatid exchange rate].
    Träder JM; Warecka K; Schwinger E
    Fortschr Neurol Psychiatr; 1985 Apr; 53(4):134-7. PubMed ID: 3997038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence of multiple sclerosis in south east Wales.
    Swingler RJ; Compston DA
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1520-4. PubMed ID: 3265431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple sclerosis genetics 2010.
    McElroy JP; Oksenberg JR
    Neurol Clin; 2011 May; 29(2):219-31. PubMed ID: 21439438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA determinants in familial multiple sclerosis.
    Grasso MG; Cutrupi F; Bernardi S; Trabace S; Pozzilli C; Cappellacci S; Fieschi C
    Neuroepidemiology; 1992; 11(2):85-9. PubMed ID: 1495578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetical aspects of multiple sclerosis with special regard to histocompatibility determinants.
    Kuwert EK
    Acta Neurol Scand Suppl; 1977; 63():23-42. PubMed ID: 66850
    [No Abstract]   [Full Text] [Related]  

  • 55. [Genetic predisposition for multiple sclerosis].
    Fontaine B; Clerget-Darpoux F
    Pathol Biol (Paris); 2000 Feb; 48(1):87-92. PubMed ID: 10729916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency of HLA-DPB1 alleles in multiple sclerosis patients from Northern Ireland.
    Middleton D; Savage DA; Cullen C; Trainor F; Mallon E; Hawkins S
    Eur J Immunogenet; 1992 Oct; 19(5):323-6. PubMed ID: 1420118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy.
    D'Alfonso S; Bolognesi E; Guerini FR; Barizzone N; Bocca S; Ferrante D; Castelli L; Bergamaschi L; Agliardi C; Ferrante P; Naldi P; Leone M; Caputo D; Ballerini C; Salvetti M; Galimberti D; Massacesi L; Trojano M; Momigliano-Richiardi P
    Genes Immun; 2008 Jan; 9(1):7-15. PubMed ID: 17928868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The major histocompatibility system, HLA, and multiple sclerosis.
    Jersild C
    Acta Neurol Scand Suppl; 1977; 63():17-21. PubMed ID: 66848
    [No Abstract]   [Full Text] [Related]  

  • 59. The HLA locus and multiple sclerosis in Sicily.
    Brassat D; Salemi G; Barcellos LF; McNeill G; Proia P; Hauser SL; Oksenberg JR; Savettieri G
    Neurology; 2005 Jan; 64(2):361-3. PubMed ID: 15668443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two-locus linkage analysis in multiple sclerosis (MS).
    Tienari PJ; Terwilliger JD; Ott J; Palo J; Peltonen L
    Genomics; 1994 Jan; 19(2):320-5. PubMed ID: 7514567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.